Ischemic liver injury.
Doherty
J C
JC
McMillen
M A
MA
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D019332:Endothelin-1 / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000494:pharmacology; D019333:Endothelin-2 / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival; D006801:Humans; D007371:Interferon-gamma / Q000032:analysis; D007376:Interleukin-2 / Q000032:analysis; D007511:Ischemia / Q000517:prevention & control*; D008099:Liver / Q000098:blood supply* / Q000473:pathology; D016031:Liver Transplantation / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D010835:Phytohemagglutinins / Q000494:pharmacology; D015427:Reperfusion Injury / Q000517:prevention & control; D015854:Up-Regulation
D000911:Antibodies, Monoclonal; D019332:Endothelin-1; D019333:Endothelin-2; D007376:Interleukin-2; D008934:Mitogens; D010835:Phytohemagglutinins; D007371:Interferon-gamma